J 2023

Gender Difference in the Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry

GIUSEPPE, De Luca; Stephane MANZO-SILBERMAN; Magdy ALGOWHARY; Berat UGUZ; Dinaldo C OLIVEIRA et. al.

Basic information

Original name

Gender Difference in the Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry

Authors

GIUSEPPE, De Luca (guarantor); Stephane MANZO-SILBERMAN; Magdy ALGOWHARY; Berat UGUZ; Dinaldo C OLIVEIRA; Vladimir GANYUKOV; Oliver BUSLJETIK; Miha CERCEK; Lisette OKKELS; Poay Huan LOH; Lucian CALMAC; Roura i Ferrer GERARD; Alexandre QUADROS; Marek MILEWSKI; di Uccio Fortunato SCOTTO; von Birgelen CLEMENS; Francesco VERSACI; Ten Berg JURRIEN; Gianni CASELLA; Aaron Wong Sung LUNG; Petr KALA (203 Czech Republic, belonging to the institution); Jose Luis Diez GIL; Xavier CARRILLO; Maurits DIRKSEN; Victor BECERRA; Michael Kang-yin LEE; Dafsah Arifa JUZAR; Rodrigo de Moura JOAQUIM; Roberto PALADINO; Davor MILICIC; Periklis DAVLOUROS; Nikola BAKRACESKI; Filippo ZILIO; Luca DONAZZAN; Adriaan KRAAIJEVELD; Gennaro GALASSO; Lux ARPAD; Lucia MARINUCCI; Vincenzo GUIDUCCI; Maurizio MENICHELLI; Alessandra SCOCCIA; Aylin Hatice YAMAC; Kadir Ugur MERT; Flores Rios XACOBE; Tomas KOVARNIK; Michal KIDAWA; Jose MOREU; Vincent FLAVIEN; Enrico FABRIS; Inigo Lozano MARTINEZ-LUENGAS; Marco BOCCALATTE; Francisco Bosa OJEDA; Carlos ARELLANO-SERRANO; Gianluca CAIAZZO; Giuseppe CIRRINCIONE; Hsien-Li KAO; Juan Sanchis FORES; Luigi VIGNALI; Helder PEREIRA; Santiago ORDONEZ; Alev Arat OZKAN; Bruno SCHELLER; Heidi LEHTOLA; Rui TELES; Christos MANTIS; Ylitalo ANTTI; Joao Antonio Brum SILVEIRA; Cesar Rodrigo ZONI; Ivan BESSONOV; Giuseppe UCCELLO; George KOCHIADAKIS; Dimitrios ALEXOPULOS; Carlos E URIBE; John KANAKAKIS; Benjamin FAURIE; Gabriele GABRIELLI; Alejandro Gutierrez BARRIOS; Juan Pablo BACHINI; Alex ROCHA; Frankie C C TAM; Alfredo RODRIGUEZ; Antonia Anna LUKITO; Veauthyelau SAINT-JOY; Gustavo PESSAH; Andrea TUCCILLO; Alfonso IELASI; Giuliana CORTESE; Guido PARODI; Mohamed Abed BOURAGHDA; Marcia MOURA; Elvin KEDHI; Pablo LAMELAS; Harry SURYAPRANATA; Matteo NARDIN and Monica VERDOIA

Edition

Journal of Clinical Medicine, BASEL, MDPI, 2023, 2077-0383

Other information

Language

English

Type of outcome

Article in a journal

Field of Study

30218 General and internal medicine

Country of publisher

Switzerland

Confidentiality degree

is not subject to a state or trade secret

References:

Impact factor

Impact factor: 3.000

RIV identification code

RIV/00216224:14110/23:00130701

Organization unit

Faculty of Medicine

UT WoS

000952085800001

EID Scopus

2-s2.0-85147814169

Keywords in English

gender; ST-segment elevation myocardial infarction; percutaneous coronary intervention; COVID-19

Tags

Tags

International impact, Reviewed
Changed: 2/5/2023 12:41, Mgr. Tereza Miškechová

Abstract

In the original language

Background. Several reports have demonstrated the impact of the COVID-19 pandemic on the management and outcome of patients with ST-segment elevation myocardial infarction (STEMI). The aim of the current analysis is to investigate the potential gender difference in the effects of the COVID-19 pandemic on mechanical reperfusion and 30-day mortality for STEMI patients within the ISACS-STEMI COVID-19 Registry. Methods. This retrospective multicenter registry was performed in high-volume primary percutaneous coronary intervention (PPCI) centers on four continents and included STEMI patients undergoing PPCIs in March-June 2019 and 2020. Patients were divided according to gender. The main outcomes were the incidence and timing of the PPCI, (ischemia time >= 12 h and door-to-balloon >= 30 min) and in-hospital or 30-day mortality. Results. We included 16683 STEMI patients undergoing PPCIs in 109 centers. In 2020 during the pandemic, there was a significant reduction in PPCIs compared to 2019 (IRR 0.843 (95% CI: 0.825-0.861, p < 0.0001). We did not find a significant gender difference in the effects of the COVID-19 pandemic on the numbers of STEMI patients, which were similarly reduced from 2019 to 2020 in both groups, or in the mortality rates. Compared to prepandemia, 30-day mortality was significantly higher during the pandemic period among female (12.1% vs. 8.7%; adjusted HR [95% CI] = 1.66 [1.31-2.11], p < 0.001) but not male patients (5.8% vs. 6.7%; adjusted HR [95% CI] = 1.14 [0.96-1.34], p = 0.12). Conclusions. The COVID-19 pandemic had a significant impact on the treatment of patients with STEMI, with a 16% reduction in PPCI procedures similarly observed in both genders. Furthermore, we observed significantly increased in-hospital and 30-day mortality rates during the pandemic only among females. Trial registration number: NCT 04412655.